<DOC>
	<DOC>NCT01995526</DOC>
	<brief_summary>The main purpose of this study is to evaluate how the body processes the study drug known as insulin peglispro and how the study drug affects blood sugar in healthy male Japanese participants. This study will also evaluate safety of the study drug. The study will last up to 46 days for each participant, not including screening.</brief_summary>
	<brief_title>A Study of Insulin Peglispro in Healthy Male Japanese Participants</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Participants are overtly healthy male Japanese. Participants have Body Mass Index (BMI) between 18.5 and 25.0 kilogram per square meter (kg/m^2), inclusive. Participants have known allergies to insulin peglispro, related compounds. Participants have a fasting venous blood glucose &gt;108 milligram per deciliter (mg/dL) (&gt;6 millimole per liter [mmol/L]).</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>